Search

everythinglearnresearchcommunity

for

Search:↓

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Late pregnancy helps repair brain damage in rats due to the GABAergic system.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

A herbal extract may help treat certain types of hair loss by reducing a specific gene's activity.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Topical vitamin D is effective in treating vitiligo with few side effects.

Fetal skin has unique immune cells different from adult skin.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Secukinumab can cause hair loss, which may improve after stopping the medication.

SH-MSCs gel reduced IL-6 and increased TGF-β, suggesting it could treat alopecia.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Calcium signals and SHH guide the direction of feather growth in chicken skin.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

The meeting discussed vitamin D3's role in fighting tuberculosis, potential treatments for skin conditions like psoriasis, and hair follicle regeneration as a possible solution for hair loss.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.